New Gut Mast Cells Mediator for Severe Food Allergic Reactions
Posted: 13th February 2026 | Posted by allergy
Scientists Discover a New Gut Mast Cell Mediator for Severe Food Allergic Reactions

Gut mast cells and leukotriene release in severe food allergy and anaphylaxis.
Researchers discovered that specialised mast cells in the gut lining can trigger life-threatening allergic reactions through powerful inflammatory chemicals – even before allergens enter the bloodstream.
The research, available via PubMed Central, helps explain why swallowing even a tiny amount of a food allergen can rapidly cause whole-body symptoms.
Why This Discovery Matters for Severe Food Allergy
Food allergies affect millions of people in the UK and worldwide. In susceptible individuals, exposure to even trace amounts of allergenic food can trigger anaphylaxis — a medical emergency characterised by:
- Difficulty breathing
- Swelling of the throat or tongue
- A sudden drop in blood pressure
- Dizziness or fainting
- Skin reactions such as urticaria (hives)
Although the mechanisms behind injected or inhaled allergen reactions are well described, the biological pathways driving gut-initiated anaphylaxis have remained poorly understood.
Key scientific question: What initiates systemic anaphylaxis when an allergen is eaten?
The Role of Gut Mast Cells in Food-Induced Anaphylaxis
Mast cells are tissue-resident immune cells central to IgE-mediated allergic reactions. Upon allergen exposure, IgE antibodies cross-link on the mast cell surface, triggering rapid mediator release.
The study demonstrates that intestinal mast cells differ significantly from mast cells found in the skin or lungs.
Distinct Characteristics of Intestinal Mast Cells
- Reside directly within the intestinal epithelial layer
- Are shaped by signals from surrounding gut epithelial cells
- Produce comparatively lower levels of histamine
- Generate substantially higher levels of leukotrienes
This unique gut mast cell phenotype suggests that food-triggered allergic reactions follow a distinct biological pathway compared with parenteral allergen exposure.
Leukotrienes – A Major Driver of Severe Food Allergy Reactions
Leukotrienes are lipid-derived inflammatory mediators synthesised via the 5-lipoxygenase pathway. They are well recognised in asthma for promoting airway narrowing, vascular permeability, and tissue inflammation.
The study found that during food-induced anaphylaxis:
- Leukotrienes are dominant mediators of systemic reaction severity
- Pharmacological blockade of leukotriene synthesis significantly reduced severe reactions in experimental models
- Antihistamines alone were less effective in preventing systemic symptoms
By contrast, allergic reactions triggered by injected allergens relied more heavily on histamine release.
This may explain why antihistamines are often insufficient in preventing severe food allergy reactions.
How Food-Induced Anaphylaxis May Begin in the Gut
Based on the experimental findings, researchers propose the following mechanism:
- A food allergen is ingested
- The allergen crosses the intestinal epithelial barrier
- IgE antibodies activate mast cells within the gut lining
- Gut mast cells release large quantities of leukotrienes
- Systemic inflammation develops, leading to anaphylaxis
This model reframes severe food allergy as a gut-initiated immune event rather than purely a circulating allergic response.
Why Some Food Allergy Reactions Are More Severe
The research suggests that severity of food-induced anaphylaxis may depend on:
- Mast cell density within the intestinal mucosa
- Magnitude of leukotriene production
- Integrity of the intestinal barrier
- Local immune and epithelial signalling pathways
These biological variables may explain why some individuals experience mild oral symptoms while others develop life-threatening systemic reactions.
Implications for Future Food Allergy Treatment
An important clinical implication is that leukotriene-targeting medications already exist and are widely used in asthma management.
In experimental models:
- Blocking leukotriene pathways significantly reduced reaction severity
- Combined targeting of histamine and leukotrienes may offer enhanced protection
However:
- Current evidence is largely based on animal models
- Human clinical trials are required
- Standard management guidelines remain unchanged
Patients with diagnosed severe food allergy must continue to:
- Avoid known trigger foods
- Carry adrenaline auto-injectors at all times
- Seek urgent medical attention if symptoms occur
The Gut as a Central Immune Organ in Allergy
This discovery reinforces the concept that the intestine functions as a major immune organ. Constant exposure to dietary proteins and microbes requires careful immune regulation. When tolerance mechanisms fail, severe food allergic reactions may result.
Understanding the role of gut mast cells and leukotrienes in food-induced anaphylaxis may transform future approaches to risk prediction, prevention, and targeted therapy.
Key Take-Home Messages
- Gut mast cells play a central role in severe food allergy
- Leukotrienes — not just histamine — drive food-induced anaphylaxis
- Targeting leukotriene pathways represents a promising therapeutic strategy
- Current emergency management recommendations remain essential
This research provides a major step forward in understanding the biological mechanisms underlying life-threatening food allergic reactions.
